Nautilus Biotechnology Inc (NAUT) — Financial Flexibility Index
Nautilus Biotechnology Inc (NAUT) has a Financial Flexibility Index of -0.33x as of September 2025. Free cash flow of $-10.62 Million (operating CF $-11.03 Million minus capex $418.00K) represents 0% of total liabilities ($31.78 Million). Check NAUT PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nautilus Biotechnology Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Nautilus Biotechnology Inc across 7 annual periods. See Nautilus Biotechnology Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Nautilus Biotechnology Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Nautilus Biotechnology Inc. For the full company profile including market capitalisation, see market value of Nautilus Biotechnology Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.68x | $-57.02 Million | $-59.15 Million | $34.01 Million | ▼ -36.8% |
| 2023 | -1.23x | $-49.27 Million | $-51.71 Million | $40.21 Million | ▲ +1.0% |
| 2022 | -1.24x | $-43.48 Million | $-45.81 Million | $35.13 Million | ▼ -16.8% |
| 2021 | -1.06x | $-36.97 Million | $-39.24 Million | $34.87 Million | ▼ -830.3% |
| 2020 | -0.11x | $-13.07 Million | $-14.00 Million | $114.73 Million | ▲ +99.4% |
| 2019 | -17.83x | $-8.74 Million | $-9.66 Million | $490.00K | ▼ -953.6% |
| 2018 | -1.69x | $-238.30 Million | $-238.30 Million | $140.82 Million | — |